BACKGROUND: Data on survival endpoints are usually summarised using either hazard ratio, cumulative number of events, or median survival statistics. Network meta-analysis, an extension of traditional pairwise meta-analysis, is typically based on a single statistic. In this case, studies which do not report the chosen statistic are excluded from the analysis which may introduce bias. METHODS: In this paper we present a tutorial illustrating how network meta-analyses of survival endpoints can combine count and hazard ratio statistics in a single analysis on the hazard ratio scale. We also describe methods for accounting for the correlations in relative treatment effects (such as hazard ratios) that arise in trials with more than two arms. Com...
Network meta-analysis (NMA) combines direct and indirect evidence from trials to calculate and rank...
Organisations such as the National Institute for Health and Care Excellence require the synthesis of...
BACKGROUND: Network meta-analysis, a method to synthesise evidence from multiple treatments, has inc...
BACKGROUND: Data on survival endpoints are usually summarised using either hazard ratio, cumulative ...
BACKGROUND: Data on survival endpoints are usually summarised using either hazard ratio, cumulative ...
Pooling the hazard ratios is not always feasible in meta-analyses of two-arm survival studies, becau...
Figure 1. A) Overall survival hazard plots in evidence network for the pooled Checkmate 017-057 t...
Background: Network meta-analysis (NMA) enables simultaneous comparison of multiple treatments whil...
Odds ratios (ORs) and relative risks (RRs) are sensitive to the length of follow-up. In meta-analyse...
In a meta-analysis of randomized controlled trials with time-to-event outcomes, an aggregate data ap...
BACKGROUND Network meta-analysis, a method to synthesise evidence from multiple treatments, has i...
Abstract Background Time-to-event data is frequently reported in both clinical and preclinical resea...
In most of meta-analyses of aggregated survival data, a pooled measure of the intervention's effect ...
© 2015 Cameron et al. Network meta-analysis is increasingly used to allow comparison of multiple tre...
Network meta-analysis is increasingly used to allow comparison of multiple treatment alternatives si...
Network meta-analysis (NMA) combines direct and indirect evidence from trials to calculate and rank...
Organisations such as the National Institute for Health and Care Excellence require the synthesis of...
BACKGROUND: Network meta-analysis, a method to synthesise evidence from multiple treatments, has inc...
BACKGROUND: Data on survival endpoints are usually summarised using either hazard ratio, cumulative ...
BACKGROUND: Data on survival endpoints are usually summarised using either hazard ratio, cumulative ...
Pooling the hazard ratios is not always feasible in meta-analyses of two-arm survival studies, becau...
Figure 1. A) Overall survival hazard plots in evidence network for the pooled Checkmate 017-057 t...
Background: Network meta-analysis (NMA) enables simultaneous comparison of multiple treatments whil...
Odds ratios (ORs) and relative risks (RRs) are sensitive to the length of follow-up. In meta-analyse...
In a meta-analysis of randomized controlled trials with time-to-event outcomes, an aggregate data ap...
BACKGROUND Network meta-analysis, a method to synthesise evidence from multiple treatments, has i...
Abstract Background Time-to-event data is frequently reported in both clinical and preclinical resea...
In most of meta-analyses of aggregated survival data, a pooled measure of the intervention's effect ...
© 2015 Cameron et al. Network meta-analysis is increasingly used to allow comparison of multiple tre...
Network meta-analysis is increasingly used to allow comparison of multiple treatment alternatives si...
Network meta-analysis (NMA) combines direct and indirect evidence from trials to calculate and rank...
Organisations such as the National Institute for Health and Care Excellence require the synthesis of...
BACKGROUND: Network meta-analysis, a method to synthesise evidence from multiple treatments, has inc...